Advertisement

FDA Approves Conjugated Estrogen plus Bazedoxifene for Symptomatic Postmenopausal Women

News in Context |
October 9, 2013

FDA Approves Conjugated Estrogen plus Bazedoxifene for Symptomatic Postmenopausal Women

Advertisement